Free Trial

Altria (A3 Neg, BBB Pos, BBB S) First manufacturer to win methanol flavoured vaping approval

CONSUMER STAPLES
  • "Four menthol-flavored e-cigarettes made by Altria Group's NJOY brand won U.S authorization, becoming the first menthol vaping devices to be cleared by federal regulators." - WSJ. Altria has responded with "Altria is 'Moving Beyond Smoking', taking action to transition millions of adult smokers to potentially less harmful alternatives. We’re pleased the FDA has determined that NJOY menthol e-vapor products are appropriate for the protection of public health".
  • FDA ultimately saw benefits for adults switching from cigarettes as larger vs. methanol flavour appeal to young individuals.
  • BofA analyst were quick to upgrade the stock to $47 from $45 (still on neutral) adding benefits to be more acute when new Fed. task force cracks down on illicit sellers. For credit we still prefer diversified exposure from BAT, Altria 31s trade flat to the former's curve.
  • FDAPressor& Altira Pressor.
136 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • "Four menthol-flavored e-cigarettes made by Altria Group's NJOY brand won U.S authorization, becoming the first menthol vaping devices to be cleared by federal regulators." - WSJ. Altria has responded with "Altria is 'Moving Beyond Smoking', taking action to transition millions of adult smokers to potentially less harmful alternatives. We’re pleased the FDA has determined that NJOY menthol e-vapor products are appropriate for the protection of public health".
  • FDA ultimately saw benefits for adults switching from cigarettes as larger vs. methanol flavour appeal to young individuals.
  • BofA analyst were quick to upgrade the stock to $47 from $45 (still on neutral) adding benefits to be more acute when new Fed. task force cracks down on illicit sellers. For credit we still prefer diversified exposure from BAT, Altria 31s trade flat to the former's curve.
  • FDAPressor& Altira Pressor.